was based on the presence of spontaneous pacemaker firing of wide (~2 ms) action potentials at 1-5 Hz in cell-attached mode and the presence of a D2-IPSC or outward current to exogenously applied D2 receptor agonists. 5-HT neurons in the DR were identified by their location on the midline, ventral to the cerebral aqueduct, as well as slow, broad, and regular action potential firing upon current injection (Kirby et al., 2003; Li et al., 2001) determined in current clamp mode within 2 min of break-in. Cells were voltage-clamped at -60 mV with an Axopatch 200B or 1D amplifier (Molecular Devices). Series resistance was monitored to ensure stable electrical access to the cell throughout the experiment (< 15 MΩ). Transmitter release was evoked by a single (0.5 ms) or train of electrical stimuli (5 x 0.5 ms pulses at 40 Hz), or in ePet-Cre +/-/Ai32 +/slices with a 5-15 ms, 470 nm LED pulse. 4-aminopyridine (100 µM) was used in the SN to enhance transmitter release from 5-HT terminals ( Figure S2 ). Currents were isolated with the presence of the following receptor blockers in the external bath solution: picrotoxin (100 µM), DNQX (10 µM), hexamethonium (50 µM, SN only), CGP 55845 (100 nM, SN only), and prazosin (100 nM, DR only). All drugs were applied through bath perfusion, except dopamine, which was applied by iontophoresis. 5-HT1B/D receptors were activated with 5-CT (100 nM) or the selective agonist sumatriptan (1 µM). The results using either agonist were not different and data were combined. Synaptic and agonist-induced current peaks were determined by averaging the current ±20 ms from the greatest upward deflection. For each cell, 3-12 consecutive currents were averaged to determine amplitude, time-to-peak, and duration at 20% of the peak. sIPSCs were detected as previously described (Gantz et al., 2013) . Data were acquired using AxoGraph software (AxographX) and LabChart 7 (AD Instruments) and were post-hoc filtered.
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